Evidence map›Paper›PMID 38951816›Full record

ArticleLipids in health and disease2024

Metagenomic and metabolomic analysis showing the adverse risk-benefit trade-off of the ketogenic diet.

Hongyan Qiu, Chengxia Kan, Fang Han, Youhong Luo, Na Qu, Kexin Zhang, Yanhui Ma, Ningning Hou, Di Wu, Xiaodong Sun and 1 more

Abstract read
In one paragraph

Article in Lipids in health and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Food science & nutrition · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. The Interplay between the Gut and Ketogenic Diets in Health and Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hongyan QiuDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Chengxia KanDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Fang HanDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Youhong LuoDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Na QuDepartment of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Kexin ZhangDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Yanhui MaDepartment of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Ningning HouDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Di WuDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China.
Xiaodong SunDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China. xiaodong.sun@sdsmu.edu.cn.ORCID http://orcid.org/0000-0001-7775-2823
Junfeng ShiDepartment of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China. jfshi@sdsmu.edu.cn.ORCID http://orcid.org/0000-0003-3950-4073

Funding

Education, Teaching and Research Projects of Weifang Medical University 2022YB033National Natural Science Foundation of China 82170865Natural Science Foundation of Shandong Province of China ZR2021QD132Natural Science Foundation of Shandong Province of China ZR2022QH013Shandong Province Medical and Health Science and Technology Development Project 202003060400Taishan Scholars Project of Shandong Province tsqn202211365
6 · The paper itself

Abstract

backgroundKetogenic diets are increasingly popular for addressing obesity, but their impacts on the gut microbiota and metabolome remain unclear. This paper aimed to investigate how a ketogenic diet affects intestinal microorganisms and metabolites in obesity.

methodsMale mice were provided with one of the following dietary regimens: normal chow, high-fat diet, ketogenic diet, or high-fat diet converted to ketogenic diet. Body weight and fat mass were measured weekly using high-precision electronic balances and minispec body composition analyzers. Metagenomics and non-targeted metabolomics data were used to analyze differences in intestinal contents.

resultsObese mice on the ketogenic diet exhibited notable improvements in weight and body fat. However, these were accompanied by a significant decrease in intestinal microbial diversity, as well as an increase in Firmicutes abundance and a 247% increase in the Firmicutes/Bacteroidetes ratio. The ketogenic diet also altered multiple metabolic pathways in the gut, including glucose, lipid, energy, carbohydrate, amino acid, ketone body, butanoate, and methane pathways, as well as bacterial secretion and colonization pathways. These changes were associated with increased intestinal inflammation and dysbiosis in obese mice. Furthermore, the ketogenic diet enhanced the secretion of bile and the synthesis of aminoglycoside antibiotics in obese mice, which may impair the gut microbiota and be associated with intestinal inflammation and immunity.

conclusionsThe study suggest that the ketogenic diet had an unfavorable risk-benefit trade-off and may compromise metabolic homeostasis in obese mice.

Indexed as

Diet, High-FatDiet, KetogenicGastrointestinal MicrobiomeMetagenomicsObesityAnimalsBody WeightDysbiosisMaleMetabolomeMetabolomicsMiceMice, Inbred C57BLGut microbiotaHigh-fat dietKetogenic dietMetabolomeMetagenomeObesity

Identifiers

PMID38951816
PMCPMC11218088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.